CD8A and neoplasm: Altogether, these data demonstrate that combination treatment, but not individual treatments, promoted the infiltration of tumor-reactive CD8+ T cells with a highly activated phenotype, while reducing the frequency of T cell–suppressive DCs and MDSCs.